Skip Nav Destination
Issues
February 2022
-
Cover Image
Cover Image
In this issue of Clinical Science (volume 136, issue 4), Liang et al. identify microbial metabolite butyrate as a novel mediator of macrophage-goblet cell crosstalk in Ulcerative colitis. The cover image features the representative immunohistochemically stained sections counterstained with Alcian blue, showing enhanced expression of SPDEF in mouse colon tissue after butyrate treatment.Close Modal
ISSN 0143-5221
EISSN 1470-8736
In this Issue
Research Articles
Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms
Lunbo Tan; Zhilong Chen; Fen Sun; Zhuoqun Zhou; Baozhen Zhang; Baobei Wang; Jie Chen; Mengxia Li; Tianxia Xiao; Rugina I. Neuman; Jianmin Niu; Koen Verdonk; Xifeng Lu; Jian V. Zhang; A.H. Jan Danser; Qing Yang; Xiujun Fan
Clin Sci (Lond) (2022) 136 (4): 257–272.
Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway
Bohao Liu; Zhong Wang; Ruyuan He; Rui Xiong; Guorui Li; Lin Zhang; Tinglv Fu; Chenyuan Li; Ning Li; Qing Geng
Clin Sci (Lond) (2022) 136 (4): 273–289.
Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway
Clin Sci (Lond) (2022) 136 (4): 291–307.